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1. Introduction 
The pioneering work of Hans Selye (1936) led to the use of the word “stress” in a biological 
context gaining popularity world-wide. Stress is as an organic response to stressors that can 
be aversive stimuli or unknown situations capable of compromising homeostasis. During 
the stress reaction, the sympathetic nervous system and hypothalamic–pituitary–adrenal 
axis are stimulated. Consequently, serum concentrations of classical stress hormones, 
namely catecholamines and glucocorticoids, are increased and act on cells and tissues 
inducing adaptive changes in order to protect the organism and allow its survival. In 
addition, the stress reaction can also modulate immune system activities and the secretion of 
other hormones (gonadotrophins, estrogen, testosterone, thyroid, angiotensins). 
Considering that organic homeostatic systems are subject to frequent environmental and 
internal variations, Sterling and Eyer (1988) proposed the term alostasis to describe the 
adaptative processes that actively maintain stability through physiological changes. 
The terms eustress and efficient allostasis describe facile adaptation, such as a quick peak 
stress response to mobilize energy to deal with an acute stressor, and a rapid return to 
baseline, when the stressor terminates. On the other hand, distress or allostatic load refers to 
an imbalance in systems that promote adaptation (Epel, 2009; Korte et al., 2005). This 
imbalance can simply be the result of too much repeated stress, but it can also be the result 
of adaptative systems that are out of balance and fail to shut-off or, alternatively, systems 
that fail to return to normal (Epel, 2009). Therefore the shut-off of the stress response is 
particularly important, because, when systems do not shut off in time, they can cause 
damage or promote pathology (McEwen, 1998). 
The classical stress hormones, glucocorticoids (cortisol) and catecholamines (epinephrine 
and norepinephrine), are catabolic and modulate the breakdown of glycogen, triglycerides 
and proteins into molecules that can be rapidly metabolized in order to generate energy 
(Black, 2002). These responses enable energy substrates to be directed to organs and tissues 
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with the greatest demand during the stress reaction, and support the fight or flight reaction 
to a stressor. 
During acute stress, there is a rapid and transient increase in blood concentrations of total 
cholesterol, low-density lipoprotein (LDL), apoprotein B, triglycerides, and free fatty acids 
(Stoney, 2007). This increase persists as along as the stressor is maintained (Black, 2002), and 
disappears in stress-free periods (Stoney et al., 1999). In chronic stress situations, it has been 
shown that dyslipidemia is maintained and may persist even after the stressor is no longer 
present (Neves et al., 2009). 
2. Dyslipidemia induced by stress: Physiological mechanisms  
Many studies have shown the effect of stress on lipid metabolism. Stress associated with a 
major disaster, such as an earthquake or loss of job and income is associated with increased 
total cholesterol, LDL, and triglycerides in the bloodstream (Stoney, 2007). The perception of 
increased stress during a period of high workload is associated with elevated cholesterol in 
the bloodstream and ingestion of foods that increase cholesterol (McCann et al., 1990). Acute 
psychological stress in healthy men and women reduces the clearance rate of exogenous fat 
(Stoney et al., 2002). Chronic psychological stress increased the plasma cholesterol level in 
medical students (O’Donnell et al., 1987). In a more recent study, Yoo et al., 2011, showed 
high prevalence of hypercholesterolemia in stressed female law enforcement officers in 
comparison with the general female population. Moreover, elevated basal cortisol 
concentrations and lower circadian cortisol variability can induce dyslipidemia in patients 
with depressive and anxiety disorders (Venn et al., 2009; Vogelzangs et al., 2007). These 
patients presented hypercortisolism, increased serum levels of total cholesterol, LDL, and 
triglycerides and decreased serum levels of HDL (Venn et al., 2009). 
In animal studies, it has been shown that electric shock stress increases plasma cholesterol 
concentrations (Berger et al., 1980), and unpredictable immobilization stress decreases HDL, 
increases blood LDL, and very-low-density lipoprotein (VLDL) concentrations in rats 
(Bryant et al., 1988). Chronic mild unpredictable stress increases triglycerides, total 
cholesterol, VLDL, and LDL concentrations in the bloodstream of stressed rats compared 
with control rats and this effect was observed 15 days after the stress protocol had ended 
(Neves et al., 2009). 
The stressful modern lifestyle exerts a strong influence on lipid metabolism (Black, 2002) 
and may transform adaptative responses to pathophysiological changes. Acute increases in 
blood lipids are necessary for the individual to survive and adapt to the stressor. However 
prolonged changes in lipid metabolism induced by chronic stress can result in 
cardiovascular diseases such as atherosclerosis, coronary heart disease, and stroke (Brindley 
et al., 1993). 
The negative effects of sustained stress-induced dyslipidemia are related to a bidirectional 
relationship between stress hormones and insulin. Catecholamines directly stimulate free 
fatty acid and glycerol secretion in the bloodstream from fat depots, a process that may 
result from increased blood flow through adipose tissue or from adipose-ǃ2 adrenoceptor 
stimulation (Stoney, 2007). Stress-induced high glucocorticoid concentration exerts a 
permissive effect on these lipolytic actions of catecholamines (Brindley et al., 1993). Since 
insulin regulates triglyceride synthesis and hepatic VLDL production, insulin resistance 
results in unregulated triglyceride synthesis and VLDL production (Stoney, 2007) and 
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triglycerides are secreted by the liver in large quantities within the VLDL particles (Black, 
2003). Therefore both catecholamines and glucocorticoids antagonize the actions of 
insulin, contributing to insulin resistance (Kyrou & Tsigos, 2009; Lafontan & Langin, 
2009). 
Moreover, hyperinsulinemia acts centrally to stimulate sympathetic nervous system activity, 
resulting in increased secretion of catecholamines (Black, 2003), and the absence of 
satisfactory insulin action facilitates the actions of cortisol and glucagon, which in turn 
stimulate phosphatidate phosphohydrolase activity to synthesize hepatic triglyceride 
(Brindley et al., 1993). 
The cortisol also induces apoprotein B (apo B) secretion from the liver in the proportion of 
one apo B molecule per VLDL particle (Brindley et al., 1993), consequently increasing the 
VLDL concentrations in the bloodstream. As each VLDL particle is metabolized to 
intermediate-density lipoprotein (IDL) or LDL, the action of the cortisol that stimulates apo 
B secretion also results in increased LDL particles in the blood. Furthermore, in the presence 
of stress-induced insulin resistance, high levels of glucocorticoids suppress the hepatic LDL 
receptors, which delay LDL clearance (Stoney, 2007). 
Contributing to all these processes, it has been shown that perilipin, which coats the 
surface of lipid droplets to restrict lipase access to the triglyceride core within the droplet, 
may suffer phosphorylation and/or down-regulation by glucocorticoid action, thereby 
facilitating the lipolysis of triglycerides in fatty acids and glycerol (Xu et al., 2001). This 
sets off a vicious cycle, leading to more and more triglycerides being produced by the 
liver and secreted in VLDL particles, as a result of the stimulation of glucocorticoids and 
fatty acids. 
In addition, norepinephrine and cortisol inhibit lipoprotein lipase activity, leading to 
diminished triglyceride clearance, decrease in HDL concentration, and increase in VLDL, 
IDL, and LDL concentrations in the bloodstream (Stoney, 2007). Norepinephrine also 
diminishes hepatic triglyceride lipase activity, which in turn promotes high concentrations 
of lipoproteins rich in triglycerides in the blood (Stoney, 2007). 
In the context of stress-induced dyslipidemia, changes in food ingestion must also be 
considered. During acute stress, transient dyslipidemia and food intake inhibition are 
mediated by ǃ-adrenergic activation and increased hypothalmic corticotrophin releasing 
hormone (CRH) levels which act as catabolic signals. On the other hand, chronic activation 
of the hypothalamic-pituitary-adrenal axis has been associated with overeating and obesity 
(Dallman et al., 2004; Nishitani & Sakakibara, 2006). Many studies have supported this 
relationship. Lemieux & Coe, 1995, related that approximately 50% of women with 
posttraumatic stress disorder as a result of childhood sexual abuse were overweight, and 
also showed high concentrations of norepinephrine, epinephrine, and dopamine in urine. 
Changes in sleep-wake cycles associated with stress, resulting in sleep loss, induce 
decreased leptin levels, increased ghrelin levels, and increased hunger and appetite (Pejovic 
et al., 2010; Spiegel et al., 2004). In addition, the parent’s lifestyle can influence metabolism, 
and individuals exposed to maternal stress during intrauterine life can exhibit deregulation 
of body weight control mechanisms and blood lipid profile (De Moura, 2008). The 
relationship between excessive glucocorticoids and visceral fat accumulation has also been 
discussed by Björntorp & Rosmond, 1999. 
Thus, the typical response to chronic stress is not by way of avoiding food but by 
increasing the intake of sugar- and fat-rich comfort foods, which make people feel better 
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(Stoney, 2007; Torres & Nowson, 2007). Dallman et al., 2003, suggested that people or 
animals eat comfort food in an attempt to reduce activity in the ‘chronic stress-response 
network’ with its attendant anxiety. They suggested the following mechanism: first, in the 
periphery, glucocorticoids stimulate accretion of mesenteric energy stores; second, as the 
abdominal energy-generated (unidentified) signal increases, the negative input to 
catecholaminergic cells in the nucleus tractus solitarius reduces the synthesis of enzymes 
required for norepinephrine synthesis; third, the decreased noradrenergic signal to the 
hypothalamic paraventricular nucleus (PVN), in turn, decreases CRH synthesis and 
secretion. Thus, there is a powerful metabolic feedback control of CRH in the PVN, which 
may indirectly decrease glucocorticoid-action in the central nucleus of the amygdala; and 
thereby control anxiety (Korte et al., 2005). Consequently, all these mechanisms can lead 
to obesity and dyslipidemia due to overeating. In addition, it has been proposed that 
when chronic stress, to which animals and humans cannot easily adapt, is combined with 
high-fat high-sugar diets, it stimulates the sympathetic nerves to upregulate the 
expression of neuropeptide Y, an adrenergic cotransmitter and stress mediator. Stress and 
hypercaloric diets also increase glucocorticoid concentration in visceral fat, which in turn 
upregulates the expression of neuropeptide Y and its receptor Y2R, resulting in  
fat growth, hyperinsulinemia and hyperlipidemia (Bartolomucci et al., 2009; Kuo et al., 
2008). 
Some studies have also shown that glucocorticoid actions in the target tissues depend not 
only on circulating hormone levels, but also on intracellular glucocorticoid receptors and 
activities of both 11ǃ-Hydroxysteroid dehydrogenase type 1 (11ǃ-HSD1) and 2 (Bose et al., 
2009). The effects of glucocorticoid are enhanced by the enzyme 11ǃ-HSD1 in the stromal 
cells of visceral fat, since this enzyme catalyzes the conversion of inactive cortisone to active 
glucocorticoid in local tissue. It has been shown that transgenic knockout mice, which 
overexpress 11ǃ-HSD1 in adipose tissue, present accumulation of visceral adipose tissue, 
hypertension, dyslipidemia and glucose intolerance (Masuzaki et al., 2001; Masuzaki & 
Flier, 2003). Therefore 11ǃ-HSD1 plays an important role in the development of metabolic 
disease associated with stress (Bose et al., 2009; Walker & Stewart, 2003). 
In addition, cytokines such as interleukin 6 (IL-6), tumor necrosis factor (TNF)-ǂ, and 
leptin released from fatty cells also contribute to dyslipidemia induced by stress. IL-6 
increases the activity of 11ǃ-HSD1 with consequent expansion of visceral fat. TNF-ǂ 
induces lipolysis in adipose tissue. Both IL-6 and TNF-ǂ decrease lipoprotein lipase 
activity, contributing to the increase in triglyceride levels induced by stress (Black, 2003). 
Moreover, TNF-ǂ induces insulin resistance because it depresses insulin receptor activity 
(Yudkin et al., 2000). TNF-ǂ also induces IL-6 synthesis, and stimulates leptin synthesis, 
which acts centrally to decrease appetite and increase thermogenesis to decrease fat 
storage (Black, 2003). Leptin increases the activity of sympathetic nervous system 
centrally (Mohamed-Ali et al., 1998), which in turn stimulates increased release of TNF-ǂ 
and IL-6 from adipocytes (Black, 2003). This sympathetic nervous system hyperactivity 
induced by high levels of leptin in the bloodstream would provide an additional effect of 
catecholamines on the genesis of insulin resistance and dyslipidemia associated with 
stress in obese individuals.  
Therefore, dyslipidemia induced by stress involves complex interactions among stress 
hormones, insulin, adipose tissue metabolism and cytokines. Figure 1 indicates the 
physiological mechanisms of dyslipidemia induced by stress.  
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Fig. 1. Schematic representation of physiological mechanisms of dyslipidemia induced by 
stress. Hypothalamic-pituitary-adrenal axis (HPA), low-density lipoprotein (LDL), very-
low-density lipoprotein (VLDL), free fatty acids (FFA), neuropeptide Y (NPY), tumor 
necrosis factor (TNF-ǂ), interleukin 6 (IL-6). Solid arrows show stimulatory effects; dashed 
arrows indicate inhibitory effects. 
3. Stress, dyslipidemia and atherosclerosis: Putative mechanisms 
Atherogenic dyslipidemia is a major underlying cause of the development of 
atherosclerosis, which is an inflammatory disease (Mullick et al., 2006; Sheril et al., 2009). 
Since the stress-induced atherogenic lipid profile potentiates the effects of dietary and 
genetic factors in atherogenesis (Brindley et al., 1993), stress has been recognized as a risk 
factor for atherosclerosis (Kyrou & Tsigos, 2009; Shively et al., 2009). However, despite the 
association between dyslipidemia and atherosclerosis, many individuals develop severe 
atherosclerotic lesions associated with low serum lipid concentration, and others develop far 
more severe atherosclerosis than would be expected on the basis of a modest elevation of 
serum lipids (Kaplan et al., 1983). In this context, other effects of stress, not related 
specifically to dyslipidemia, are also involved in atherogenesis (Bierhaus et al., 2003; Gu et 
al., 2009) and approximately 40% of cases without known causal factor, have been attributed 
to stressful situations (Black, 2002). 
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The atherogenic effects of stress include changes in nitric oxide (NO) and cytokine 
production, vascular smooth muscle mitogenesis, occurrence of insulin resistance, 
neuropeptide Y (NPY) actions and modulation of the renin-angiotensin system activity. 
These effects are directly and indirectly related to stress-induced dyslipidemia, as will be 
pointed out below. 
The healthy endothelium provides a smooth barrier that limits the activation of 
proinflammatory factors, blocks the transfer of Apo-B 100-containing atherogenic lipid 
particles into subendothelial space, inhibits the release of chemokines and cytokines, and 
prevents platelet and monocyte adhesion to the vascular wall (Cersosimo & DeFronzo, 
2006). A high amount of NO is produced by endothelial nitric oxide synthase (eNOS). It is a 
vasodilator, has antithrombogenic properties, is an inhibitor of smooth muscle cell 
proliferation and of leukocyte- and monocyte-adhesion (Badimón & Martínez-González, 
2002; Sudano et al., 2006). Decrease in NO bioavailability is a key feature of endothelial 
dysfunction resulting in lower responses to vasodilator agents (Codoñer-Franch et al., 2011), 
and represents an early stage of atherosclerosis (Badimón & Martínez-González, 2002). 
Endothelial dysfunction contributes to the development and progression of atherosclerosis 
by favoring coagulation, inflammatory cell adhesion, imbalance between vasoconstriction 
and vasodilation, and by enhancing transendothelial transport of atherogenic particles 
(Cersosimo & DeFronzo, 2006). 
High stress-induced glucocorticoid levels reduce the expression of guanosine triphosphate 
cyclohydrolase 1 messenger ribonucleic acid (mRNA), necessary for tetrahydrobiopterin 
cofactor (BH4) synthesis, which stabilizes eNOS (Mitchell et al., 2004). If BH4 levels decrease, 
endothelial eNOS becomes uncoupled and transfers electrons to molecular oxygen 
generating superoxide anions (Rizzo et al., 2009), which react avidly with NO to form 
peroxynitrites (Förstermann & Münzel, 2006), resulting in diminished NO bioavailability, 
and favoring the traffic of oxidized lipids across the endothelium. Associated with this 
injurious effect of glucorticoids, the high LDL levels induced by stress also decrease eNOS 
mRNA expression (Liao et al., 1995). 
Considering dyslipidemia induced by stress, it has been reported that before structural 
changes appear, chronic elevations of cholesterol in the bloodstream are frequently 
associated with impaired endothelium-dependent NO production due to increased 
interaction between caveolin and eNOS (Feron et al., 1999). Caveolin proteins are expressed 
in the majority of the cell types that play a role in atherogenesis, including endothelial cells, 
macrophages, and smooth muscle cells (Frank & Lisanti, 2004). High levels of LDL-
cholesterol increase the caveolin concentration in endothelial cells (Feron et al., 1999), 
strengthen the calveolin-eNOS complex, and reduce the interaction between Ca2+-
calmodulin and eNOS. These effects decrease eNOS translocation from caveolae to the 
cytoplasm and considerably diminish NO production (Feron et al., 1999; Frank & Lisanti, 
2004). In addition, lipid peroxidation induced by stress also impairs nitric oxide production 
(NO), stimulates inflammatory response, and increases the traffic of inflammatory 
molecules and oxidized LDL to sub-endothelial space, leading to vascular endothelial 
dysfunction (Black, 2002; Black, 2003; Black & Garbutt, 2002; Rizzo et al., 2009). 
Insulin resistance is also involved in the atherogenic effects of stress. Insulin stimulates NO 
production by the endothelium (Muniyappa & Quon, 2007). During chronic stress cortisol-
induced insulin resistance (Black, 2002; Kyrou & Tsigos, 2009) decreases this effect, and 
endothelial dysfunction may occur. In addition, insulin resistance is associated with 
inhibition of the phosphatidylinositol 3-kinase pathway and over-stimulation of the 
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mitogen-activated protein kinase pathway in endothelial cells. Impairment of the 
phosphatidylinositol 3-kinase pathway reduces eNOS activity, and accentuates free fatty 
acid-evoked oxidative stress. These effects decrease NO bioavailability and promote an 
imbalance between vasoconstriction and vasodilation (Cersosim & DeFronzo, 2006; 
Muniyappa & Quon, 2007) predisposing the individual to atherosclerosis and arterial 
hypertension. In addition insulin resistance increases the reactive oxygen species, reducing 
eNOS activity (Muniyappa et al., 2008). 
Morphological changes in blood vessels are also associated with atherosclerosis. The 
increase in intima media thickness (IMT) in the carotid artery has been used as a marker of 
target organ damage in human hypertension (Sierra & de la Sierra, 2008). In experimental 
studies, the IMT of the aorta observed in stressed rats (Okruhlicová et al., 2008) was related 
to the atherogenic effects of stress. In healthy blood vessels, NO produced by the 
endothelium maintains the mitogenic quiescence of smooth muscle cells. Decreased NO 
bioavailability induced by stress-related glucocorticoid levels or -insulin resistance results in 
the loss of this effect and consequently vessel wall hypertrophy may occur (Costa & 
Assreuy, 2005). In fact, it has been observed that rats submitted to chronic mild 
unpredictable stress presented higher IMT and lower relaxation response to acetylcholine in 
the thoracic aorta, in comparison with non stressed animals. These effects were observed 15 
days after the end of the stress protocol and were associated with insulin resistance and 
dyslipidemia. However, in this study, the dyslipidemia induced by the hypercaloric diet 
alone, did not promote morphological or functional changes in the thoracic aorta, or insulin 
resistance evidencing the role of stress in pro-atherogenic effects (Neves et al., 2011). 
NPY, a hormone known as orexigenic peptide, may also be involved in the atherogenic 
effects of stress. Some stressors such as cold and aggression, increase the release of NPY 
from sympathetic nerves (Kuo et al., 2007). The peripheral actions of NPY are stimulatory, 
synergizing with glucocorticoids and catecholamines to potentiate the stress response. It 
causes prolonged vasoconstriction, potentiating the effect of norepinephrine, induces 
hyperlipidemia, and vascular remodeling via smooth muscle cell proliferation, in addition 
to stimulating monocyte migration and activation (Kuo et al., 2007). NPY upregulates its Y2 
receptors in a glucocorticoid-dependent manner in abdominal fat, consequently leading to 
abdominal obesity, hyperinsulinemia and dyslipidemia (Kuo et al., 2008). In blood vessels, 
Y1 and Y5 receptor activation promotes pro-atherogenic responses (Zukowska, 2005). 
In addition to all the above-mentioned mechanisms, the inflammatory process also forms 
part of the stress response (Black, 2003), and is pathophysiologically linked to 
atherosclerosis (van Oostrom et al., 2004). In the atherogenic process, the high level of 
catecholamines induced by stress stimulates endothelial permeability to the traffic of 
oxidized LDL. Once trapped in the endothelium of an artery, LDL can undergo progressive 
oxidation, cross the endothelial barrier, and be internalized by macrophages expressing 
scavenger receptors, leading to lipid peroxide formation and accumulation of cholesterol 
esters, culminating in foam cells formation (Ross, 1999; Singh & Mehta, 2003). Oxidized LDL 
upregulates the expression of adhesion molecules and secretion of chemokines, which 
contributes to the recruitment of circulating monocytes and leukocytes (Cersosimo & 
DeFronzo, 2006; Steinberg, 2002). One of the initial steps in the formation of atherosclerosis 
is the adhesion of monocytes to the endothelium, their entry into sub-endothelial space, 
followed by their differentiation into macrophages (Lamharzi et al., 2004). These cells are 
then responsible for taking up LDL and other particles, thereby starting the atherogenesis 
process (Lamharzi et al., 2004). In foam cell formation, the macrophages in the endothelial 
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space also have VLDL receptors, which bind the apolipoprotein (apo) E-containing 
lipoproteins, including VLDL, intermediate density lipoprotein, and ǃ-migrating VLDL. The 
LDL-receptor-related protein in macrophages is also capable of binding apo E-containing 
lipoproteins, lipoprotein lipase, and lipoprotein lipase-triglyceride-rich lipoprotein complex 
(Nakazato, 1996), leading to a sequence in the development of atherosclerosis. 
In addition, high levels of free fatty acids also may amplify monocyte inflammation via toll-
like receptors in the presence of high glucose levels (Dasu & Jialal, 2011). Lamharzi et al., 
2004, showed that free fatty acids in concert with glucose stimulate machrophage 
proliferation involving glucose-dependent oxidation of LDL in atherosclerotic lesions. Toll 
like receptors are expressed by machrophages in murine and human lipid-rich 
atherosclerotic plaques and upregulated by oxidized LDL (Xu et al., 2001). Recently Gu et 
al., 2009, showed the importance of toll-like receptor 4 in atherosclerosis induced by chronic 
mild stress in aortas from apolipoprotein-E-knockout-mice. Toll-like receptor 4 is present in 
T cells, monocytes, and macrophages, and is a key signaling receptor of innate immunity. 
Toll-like receptor 4 plays an important role in atherogenesis because it recognizes pathogen-
associated molecular patterns and activates inflammatory cells via the nuclear factor kB 
(NF-kB) pathway (Bierhaus et al., 2003; Gu et al., 2009). During the stress reaction, 
glucocorticoids and catecholamines can induce cytokine production by endothelial cells and 
macrophages (Black, 2003; Chae et al., 2001) and activation of the NF-kB pathway leads to 
the synthesis of the following proinflammatory chemokines: interleukin 1-ǃ, inteleukin 6, 
TNF-ǂ, monocyte chemoattractant protein-1, intercellular adhesion molecule-1. Interleukin 
1-ǃ and inteleukin 6 influences smooth muscle cell proliferation and/or migration (Gu et al., 
2009), and inhibits eNOS activity (Muniyappa et al., 2008). TNF-ǂ increases endothelin-1 
secretion, decreases NO production in endothelial cells, inducing vasoconstriction 
(Muniyappa & Quon, 2007), and can induce interleukin 6 production (Black, 2003). 
Monocyte chemoattractant protein-1 is correlated with neointimal proliferation and plays a 
role in the transition from the stable state of lesion to the more complex state of 
atherosclerosis (Tellez et al., 2011). Intercellular adhesion molecule-1 may contribute to 
accelerating atherosclerosis in insulin-resistant states (Muniyappa et al., 2008). 
Hypertriglyceridemia associated with stress may also increase NF-kB, consequently 
activating proinflammatory molecules (Fitch et al., 2011). 
In addition, the accumulation of macrophages may also be associated with increased plasma 
concentration of C-reactive protein (CRP) (Ross, 1999). CRP is the principal down-stream 
mediator of inflammatory acute phase response, which is primarily derived via interleukin 
6-dependent hepatic biosynthesis (Pradhan et al., 2001). CRP interacts with oxidized LDL to 
form proatherogenic oxidized LDL/CRP complexes, perpetuating vascular inflammation, 
triggering an autoimmune response, and accelerating atherogenesis (Matsuura et al., 2009; 
Sitia et al., 2010). 
Activation of the renin-angiotensin system (RAS) by stress also plays a role in the 
pathogenesis of endothelial dysfunction, hypertension and atherosclerosis. Lipid 
accumulation in blood vessels enhances the expression of RAS components, which in turn 
stimulates accumulation of oxidized LDL in blood vessels (Singh & Mehta, 2003). Activation 
of the angiotensin II-type 1 receptor (AT1R) leads to vasoconstriction and neurohumoral 
activation, and is associated with reduced NO bioavailability, vascular cell apoptosis, 
increased oxidized LDL receptor expression, and proinflammatory cytokine production (Sitia 
et al., 2010). According Nickening et al., 1999, LDL-cholesterol can accumulate in vascular 
smooth muscle cells, and this effect is mediated via AT1R. Angiotensin II increases LDL uptake 
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by arterial wall macrophages (Keidar et al., 1994). Angiotensin II binds LDL and the 
angiotensin II-modified LDL is taken up by macrophages via scavenger receptors, leading to 
cellular cholesterol accumulation (Keidar et al., 1996). In atherogenic dyslipidemia, 
hypercholesterolemia increases AT1R density and its functional responsiveness to 
vasoconstrictors, whereas the administration of statins reduces AT1R expression and 
deregulates its functions. Moreover, the localization of angiotensin-converting enzyme in 
atherosclerotic lesions suggests a capacity for local generation of angiotensin II and 
proinflammatory substances (Sitia et al., 2010). There is also evidence that 
hypercholesterolemia increases plasma angiotensinogen and angiotensin peptide production 
(Sitia et al., 2010), and that AT1R antagonism improves hypercholesterolemia-associated 





























































Fig. 2. Schematic representation of putative mechanisms involved in the relations between 
among stress, dyslipidemia, and atherosclerosis. Hypothalamic-pituitary-adrenal axis (HPA), 
neuropeptide Y (NPY), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), 
free fatty acids (FFA), endothelial nitric oxide synthase (eNOS), nitric oxide (NO), endothelin 1 
(ET-1). Solid arrows show stimulatory effects; dashed arrows indicate inhibitory effects. 
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Atherosclerosis is an inflammatory disease and stress contributes to its development.  
Therefore, if we can block or minimize the stress components that directly or indirectly 
induce atherogenesis, it will be possible to preserve the protective components of vascular 
function and structure, thereby developing new preventive and therapeutic possibilities. 
Figure 2 illustrates the putative mechanisms of the relations between stress, dyslipidemia, 
and atherosclerosis. 
4. Reduction of dyslipidemia induced by stress: Physical exercise and 
nutritional intervention 
The role of stress in the etiology of chronic degenerative diseases is increasingly recognized 
(Gerber & Pühse, 2009; Holmes et al., 2010; Tsatsoulis & Fountoulakis, 2006; Yin et al., 2005). 
Moreover, it has been reported that obese people have an exaggerated response to stress, 
which may further increase the risk of weight gain, leading to the development of insulin 
resistance, hyperlipidemia, diabetes mellitus, hypertension and atherosclerosis in both men 
and women. This burden of chronic degenerative diseases is strongly influenced by several 
lifestyle factors, including the way an individual perceives a stressful situation, i.e., “mental 
fitness” and also his/her general physical condition or “physical fitness” (McEwen, 1998). 
Tsatsoulis & Fountoulakis, 2006, demonstrated that stress-mediated allostatic load, in the 
presence of physical inactivity, is associated with an increased risk of mental and physical 
illness, and direct evidence for this notion has been provided by several studies. A strong 
inverse association between physical activity and the metabolic syndrome has been 
demonstrated, and several years ago this association was shown to be much steeper in unfit 
individuals (Kriska et al., 1993; Lindgärde & Saltin, 1981). Evidence for this view was also 
provided by the MacArthur studies of successful aging based on a large cohort of elderly 
men and women (Seeman et al., 1997), showing that subjects with low levels of physical and 
mental fitness had higher prevalence of cardiometabolic disease when compared with those 
with high fitness levels. Moreover, a strong association between physical inactivity, 
excessive food consumption, high-fat diet and increasing incidence of insulin resistance, 
Type 2 diabetes, (Hawley, 2004; Steanovv et al., 2011), development of obesity (Venables & 
Jeukendrup, 2009; Vessby, 2000) and depression (Win et al., 2011) has also been described in 
the literature. Considering that stress, physical inactivity, and aging (associated with 
declining physical activity and metabolic rate, coupled with an energy intake not matched to 
the declining need), in addition to a high-fat diet, are the very features of our current 
lifestyle, the incidence of this “stress-induced/exercise deficient” phenotype is becoming 
increasingly prevalent in modern society (Davy et al., 1996, Hawley, 2004, Poehlman et al., 
1995, Schiut et al., 1998, Tsatsoulis & Fountoulakis, 2006). 
Based on the above mentioned findings, it is reasonable to assume that physical inactivity may 
potentiate the stress-related allostatic load and comorbidities, since the energy substrate that is 
mobilized during stress is not oxidized but is stored in visceral fat depots. This adaptation 
creates a vicious cycle, in which perceived stress is also associated with decreased participation 
in several health behaviors including exercise, social behaviors, stress management/rest, and 
safety/environmental behaviors, as shown by Padden et al., 2011, in the study on health 
behavior of military spouses during deployment separation. In this context, physical exercise 
practiced as a non-pharmacological alternative, either with or without the association of 
pharmacological therapies, is very important, and a great deal of attention should be given to 
the barriers imposed, especially by mood disorders, including depression. Individuals in this 
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condition are at disadvantage, since most of the time they lack the energy and motivation to 
exercise, and this overwhelming feeling of lethargy seems very difficult to shift (Chaput et al., 
2011). In this situation, when psychological stress is not accompanied by physical activity 
(such as the fight or flight reaction) and by effective use and fast clearance of free fatty acids, 
triggered by stimulation of the sympathetic nervous system, these are converted into 
triglycerides by the liver and then circulate in the blood within the VLDL (Howard et al., 
1993). In fact, this maladaptative situation can lead to the development of dyslipidemia, 
reflected by elevated plasma triglyceride and reduced HDL concentration, overproduction of 
VLDL-apolipoprotein (apo) B-100, decreased catabolism of apoB containing particles, and 
increased catabolism of HDL apoA-I particles (Watts et al., 2008; Watts et al., 2009). 
While physical inactivity may potentiate the stress-induced allostatic load, there is 
accumulating evidence suggesting that the adoption of an active lifestyle, including exercise 
training, may play a protective role in stress system dysregulation, reducing vulnerability to 
stress, and possibly delaying or preventing the future development of comorbidities, such as 
dyslipidemia, hypertension and insulin resistance (Roberts & Barnard, 2005; Tsatsoulis & 
Fountoulakis, 2006). In addition, physical activity may induce favorable changes in 
traditional and emerging coronary heart disease biomarkers among individuals with, or at 
high risk of coronary heart disease (Chainani-Wu et al., 2011). Assuming that the stress 
response is a neuroendocrine mechanism that occurs in anticipation of physical action, it is 
reasonable to assume that physical activity should provide the vehicle to prevent or combat 
the somatic and emotional consequences of stress. Thus, physical activity may promote 
physical and psychological benefits that are involved in both the indirect action of exercise 
in reducing stress, and a direct effect on various metabolic functions of the body (McMurray 
& Hanckney, 2005). 
The first rationale for using exercise as a stress reduction strategy was based on the cross-
stressor adaptation, a promising hypothesis first presented in the 1990s (Sothmann et al., 1996), 
which has not received strong support since the publication of recent meta-analyses (Forcier et 
al., 2006; Hamer et al., 2006; Jackson & Dishman, 2006). According to Chaput et al., 2011, the 
key question now is whether physical activity, which seems to modulate the level of stress, 
may interact in the relationship between stress and obesity. Different possible mechanisms 
have been proposed, suggesting that exercise training might protect against stress induced 
obesity. Regular exercise has been demonstrated to have positive effects on plasma lipid and 
lipoprotein profiles (Durstine et al., 2002) and these results may have a significant independent 
effect on HDL cholesterol (Thompson et al., 1988). During physical activity, exercise increases 
lipid oxidation and lipolysis to ensure an adequate oxygen supply (McMurray & Hanckney, 
2005), increases the ability of muscle tissue to take up and oxidize nonesterified fatty acids, and 
increases muscle lipoprotein lipase activity (Eriksson et al., 1997). Although studies indicate 
that exercise training changes gene expression in adipose tissue in different ways, affecting 
some types of adipose tissue more than others (Company et al., 2010), the lowering of plasma 
triglycerides proves the effects of exercise on VLDL kinetics. Moreover, it is important to 
highlight that a single 90-min bout of whole body resistance exercise (Tsekouras et al., 2009) or 
2h of cycling (Magkos et al., 2006) was proven to be enough to decrease fasting plasma VLDL-
triglyceride concentrations by increasing VLDL-triglyceride removal from plasma. These 
results may be due to the increase in blood flow and hepatic insulin sensitivity associated with 
an increase in lipoprotein lipase activity. 
In addition to its possible direct effect modulating the stress response, exercise training 
improves insulin sensitivity, which might counteract the insulin resistance state produced 
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by chronic hypercortisolemia (Tsatsoulis & Fountoulakis, 2006). Insulin secretion could then 
be reduced, and thereby, its deleterious impact on energy intake may be diminished. 
Moreover, exercise training improves glucose tolerance among non-diabetic, non-obese 
subjects with hypertriglyceridemia (Lampman & Schteingart, 1991) and enhances the 
oxidative capacity of skeletal muscle (Tsatsoulis & Fountoulakis, 2006). Together, these 
beneficial adaptations could prevent stress-induced fat deposition by routing the energy 
mobilized in response to the stressor toward oxidation rather than storage. 
Apart from the protective effects of exercise on the physical and metabolic aspects related to 
stress, a number of psychological and cognitive benefits have also been reported in the 
literature. These include improvements in depression and anxiety scores and general 
improvement in mood, cognitive functioning (Callaghan, 2004; Tsatsoulis & Fountoulakis, 
2006), well-being and self esteem, leading to a decrease in body fat, triglycerides, LDL/HDL 
cholesterol ratio in stressed patients (De Geus & Stubbe, 2007). Physical activity can improve 
mental health by reducing depressive symptoms in young men (McGale et al., 2011) and in 
patients with metabolic syndrome (Rubenfire et al., 2011). Moreover exercise induces the 
elevation of circulating brain derived neurotrophic factor, which is known to improve the 
health and survival of nerve cells, suggesting that exercise influences brain health (Yarrow 
et al., 2010). Using animal models, exercise has also been shown to induce antidepressant 
responses (Greenwood et al., 2003). In rats, swimming exercise induces a remission of 
anhedonic symptoms suggesting that exercise training might induce biological alterations 
similar to those provided by antidepressant drugs. In addition, exercise plays an important 
role in hippocampal protection from damage caused by exposure to glucocorticoids (Sigwalt 
et al., 2011). In this context, physical activity was able to stimulate the proliferation of 
hippocampal cells (Ehninger & Kempermann, 2003), promote alterations in synaptic 
plasticity, neurogenesis and synaptogenesis (Castrén, 2005), and may also be linked to 
increased levels of brain testosterone (Mukai et al., 2006). 
Another beneficial effect of exercise is related to feeding behavior. Stressful situations have 
been shown to affect feeding behavior (Wallis & Hetherington, 2009) that result in increased 
energy intake through the stimulation provided by ingesting palatable foods that may serve 
as feedback signals that reduce the perception and discomfort of stress, thereby contributing 
to the development of dyslipidemia and obesity (Dallman et al., 2005). Moreover 
glucorticoids are associated with high neuropeptide Y secretion, which has an orexigenic 
activity and increases the intake of sugar- and fat-rich- comfort foods (Kuo et al., 2008) and 
can lead to a state of leptin resistance and elevated levels of this hormone (Zakrzewska et al., 
1997). In this context, it has been demonstrated that physical activity has the potential to 
modulate appetite control by improving the sensitivity of the physiological satiety signalling 
system, by adjusting macronutrient preferences or food choices and by altering the hedonic 
response to food (Blundell et al., 2003). Indeed, dietary modification, associated with 
physical activity has been shown to exert significantly favorable effects on the treatment and 
prevention of stress-induced comorbidities, improving glycemia, blood pressure, body 
weight, fat distribution, and lipid profile, which in turn suggest that chronic degenerative 
diseases are largely preventable (Dagogo et al., 2010). Although exercise cannot change total 
cholesterol and LDL-cholesterol unless dietary fat intake is reduced, this result may be 
dependent on the amount of energy expenditure during exercise (Durstine et al., 2002). 
Furthermore, depending on the time that the exercise is performed (before or after ingestion 
of fatty foods), its acute responses related to improvement in lipoprotein metabolism may be 
different (Hashimoto et al., 2011). In a review of several studies realized by Leon & Sanchez 
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2001, one of proposals evaluated was the effects of aerobic exercise training on blood lipids 
and the relationship between these effects and diet. The results showed that majority of 
physically active individuals had an increase in HDL cholesterol, but this could be changed if 
there was a concomitant reduction in fat intake. The association between low-fat diet and 
exercise reduces LDL and HDL-cholesterol levels. Furthermore, reductions in total cholesterol, 
LDL-cholesterol and triglyceride levels were less frequently observed. As regards body weight 
loss, there was considerable variability between the groups, ranging from 7.2 Kg in the group 
that was not exposed to dietary intervention to 17.9 Kg in the group that underwent dietary 
intervention. In addition, Rubenfire et al., 2011, demonstrated that the association between 
changes in diet and exercise was effective in reducing cardiovascular risk in patients with 
metabolic syndrome. In this study, the nutritional component was based on a Mediterranean 
food pattern, and all the participants were provided with the information needed to optimize 
their nutritional choices in order to improve blood lipid and glucose levels, decrease body 
weight and blood pressure, and decrease insulin resistance (Rubenfire et al., 2011). It has also 
been proposed that high-fiber diets protect against obesity and cardiovascular disease by 
lowering insulin levels (Ludwig et al., 1999). In obese men, the implementation of a high-fiber 
and low-fat diet associated with regular physical activity resulted in significant reductions in 
inflammation and dyslipidemia by reducing serum lipids, insulin, oxidative stress, leukocyte-
endothelial interactions (Roberts & Barnard, 2005). 
Dietary fat influences glucose and lipid metabolism by altering cell membrane function, 
enzyme activity, insulin signaling, and gene expression (Risérus et al., 2009; Yamazaki et al., 
2011) and dietary fructose consumption appears to induce dyslipidemia, obesity (Stanhope 
et al., 2009) and hypertension (Cunha et al., 2007; Farah et al., 2006). A combination of social 
stress and high-fat diet resulted in a significant imbalance in lipid regulation associated with 
changes in the expression of hepatic genes, responsible for its regulation (Chuang et al., 
2010). Therefore, clinical strategies based on low fat and sugar intake associated with 
increase in physical exercise have been used, and have contributed to reducing the risks of 
developing coronary and metabolic diseases. 
5. Conclusion 
Dyslipidemia induced by stress is part of the body’s response to cope with stressors. The 
mobilization of lipids, glucose and proteins, allows the organs and tissues to maintain 
homeostasis and adapt to the stressor. Any deficiency in the activation of this mobilization 
of energetic fuels can compromise the survival of the individual. Therefore, the increase in 
blood lipids induced by stress is adaptive and it should return to normal levels when the 
stressor ends. However, when the stressor is maintained over a long period, the 
dyslipidemia induced by stress persists and may have deleterious effects, contributing to the 
occurrence of insulin resistance, obesity, hypertension and atherosclerosis. Considering that 
physical inactivity may potentiate these effects, the association of physical exercise and 
control of hypercaloric food consumption have been used in the treatment of dyslipidemia. 
Knowledge about the physiological mechanisms involved in the adaptive role of transient 
dyslipidemia induced by acute stress, and in the deleterious effects of sustained 
dyslipidemia induced by chronic stress is very important in the improvement and 
development of preventive and therapeutic approaches because in modern society we are 
continuously exposed to stressors. 
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